LYS A 17ARG A 19GLU A 135HIS A 137CYH A 181ASN A 182ASN A 206HIS A 207TYR A 240TYR A 258PHE A 260
NoneSAM A 501 (-3.7A)SAM A 501 (-3.3A)SAM A 501 (-3.9A)SAM A 501 ( 3.4A)SAM A 501 ( 3.8A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A)6TM A 502 ( 4.2A)SAM A 501 (-3.6A)
0.26A
3s7fA-5kjmA:61.93s7fI-5kjmA:undetectable
3s7fA-5kjmA:100.003s7fI-5kjmA:5.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
ASN Z 351PRO Z 352HIS Z 353GLU Z 377HIS Z 378SER Z 379TRP Z 380TRP Z 386TRP Z 400PHE Z 402GLY X 575
85C Z 502 (-3.6A)85C Z 502 (-4.4A)85C Z 502 (-3.9A)85C Z 502 (-3.2A)85C Z 502 (-3.8A)85C Z 502 (-3.2A)85C Z 502 (-3.2A)85C Z 502 (-3.4A)85C Z 502 (-3.7A)None85C Z 502 (-3.7A)
0.55A
6h0gE-5hxbZ:51.76h0gF-5hxbZ:undetectable
6h0gE-5hxbZ:62.906h0gF-5hxbZ:10.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.